BAC vs SGMO · P/E 13, rev $113.10B vs rev $57.8M
Bank of America Corp (BAC) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported BAC revenue for 2025-12-31 was $113.10B. Net income was $30.51B. Revenue was up 11.0% from 2024-12-31 to 2025-12-31. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
BAC currently screens at market cap $382.01B and trailing P/E 13.4. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the BAC and SGMO stock pages for the full models.
Not investment advice.